ARMISTICE CAPITAL, LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$156,000
-95.5%
600,000
-70.0%
0.06%
-95.0%
Q3 2015$3,480,000
-44.6%
2,000,000
-38.3%
1.19%
-57.4%
Q1 2015$6,286,0003,240,0002.79%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders